|
Originally published In Press as doi:10.1074/jbc.M108993200 on January 2, 2002
J. Biol. Chem., Vol. 277, Issue 12, 10187-10193, March 22, 2002
The Crystal Structure of Helicobacter pylori
Cysteine-rich Protein B Reveals a Novel Fold for a Penicillin-binding
Protein*
Lucas
Lüthy,
Markus G.
Grütter, and
Peer R. E.
Mittl
From the Biochemisches Institut, Universität Zürich,
Winterthurer Strasse 190, 8057 Zürich, Switzerland
Received for publication, September 18, 2001, and in revised form, December 28, 2001
 |
ABSTRACT |
Colonization of the gastric mucosa with the
spiral-shaped Gram-negative proteobacterium Helicobacter
pylori is probably the most common chronic infection in humans.
The genomes of H. pylori strains J99 and 26695 have been
completely sequenced. Functional and three-dimensional structural
information is available for less than one third of all open reading
frames. We investigated the function and three-dimensional structure of
a member from a family of cysteine-rich hypothetical proteins that are
unique to H. pylori and Campylobacter jejuni.
The structure of H. pylori cysteine-rich protein (Hcp) B
possesses a modular architecture consisting of four / -motifs that
are cross-linked by disulfide bridges. The Hcp repeat is similar
to the tetratricopeptide repeat, which is frequently found in
protein/protein interactions. In contrast to the tetratricopeptide
repeat, the Hcp repeat is 36 amino acids long. HcpB is capable of
binding and hydrolyzing 6-amino penicillinic acid and 7-amino
cephalosporanic acid derivatives. The HcpB fold is distinct from the
fold of any known penicillin-binding protein, indicating that the Hcp
proteins comprise a new family of penicillin-binding proteins. The
putative penicillin binding site is located in an amphipathic groove on
the concave side of the molecule.
 |
INTRODUCTION |
The large number of protein sequences that have been derived
by more than 80 genome sequencing projects of archaea, bacteria, and eukaryotes (www.cbs.dtu.dk/services/GenomeAtlas/) has provided the
scientific community with sequences where neither a function nor a
three-dimensional structure is available. These sequences, which are
annotated as "hypothetical proteins," will become a rich source of
information, provided that their structures and biological functions
are investigated. Here we present the structure and function analysis
of a hypothetical protein from the pathogenic microorganism
Helicobacter pylori. Several implications of H. pylori on human health have been established since its discovery in 1983 by Warren and Marshal (1). It is generally accepted that
gastric diseases such as duodenal ulcers, gastric ulcers, adenocarcinoma of the distal stomach, and gastric mucosa-associated lymphoid tissue lymphoma are caused by H. pylori, and its
implication in extradigestive diseases is under discussion. Infection
by H. pylori has also been linked to dyspepsia and to a
multitude of non-gastric diseases including cardiovascular, autoimmune,
dermatological, and liver diseases. Implications of H. pylori on human health have been reviewed in several articles
(2-5). In addition, it has also been reported that H. pylori infection may be beneficial and protect against gastric
esophageal reflux disease (6).
The H. pylori genomes of strains 26695 and J99 have been
completely sequenced, facilitating a detailed genome analysis (7, 8).
For approximately two-thirds of all H. pylori
ORFs,1 functions were
assigned by sequence comparison methods, and for approximately
one-third, the three-dimensional structure of a homologous protein is
available. Among the ORFs without a functional annotation, there is a
group of hypothetical proteins that are rich in cysteine residues.
Therefore the corresponding gene products are designated
Helicobacter cysteine-rich proteins (Hcp) (9, 10). The Hcps,
which are so far unique to microorganisms from the
Helicobacter and Campylobacter genera,
possess molecular sizes in the range between 15 and 40 kDa and
show a stringent pattern of cysteine pairs. Two cysteine residues are
separated by 7 amino acids, and there are 36 amino acids between
adjacent cysteine pairs, suggesting that the Hcp proteins possess
modular architectures of repetitive / -motifs. Sequence
conservation among this family varies between 22 and 66% sequence
identity (Fig. 1). It was shown recently
that the Helicobacter cysteine-rich protein A (HcpA) possesses a -lactamase activity, although there was no detectable sequence homology to known -lactamases (10). To work toward a
functional and structural characterization of the Hcp family, we
expressed and characterized the HP0336 gene product, designated HcpB, and determined its crystal structure. The HcpB structure possesses a fold that is related to the structures of tetratricopeptide repeat proteins. This fold has so far never been observed for a
penicillin-binding protein.

View larger version (82K):
[in this window]
[in a new window]
|
Fig. 1.
Multiple sequence alignment of the Hcp
family generated with the program CLUSTALX (33). Residues that are
predicted by the SignalP server (34) to form leader peptides are
underlined, and residues that form -helices in the HcpB
structure are shown in bold characters. Cysteine pairs are
highlighted by gray bars. The protein nomenclature suggested
earlier (9,10) is expanded to the entire Hcp family. At the end of each
sequence, the number of residues, the number of
cysteine pairs (in parentheses), and the names of
the ORFs are given. ORFs starting with JHP, HP,
and CJ refer to the H. pylori strain J99 (8),
strain 26695 (7), and Campylobacter jejuni strain NCTC11168
genomes (35), respectively. In cases where orthologues in both H. pylori strains exist, only the sequence from the J99 strain is
given.
|
|
 |
MATERIALS AND METHODS |
Molecular Biology and Protein
Expression--
The plasmid GHPDN49 harboring the ORF HP0336
was obtained from the American Tissue and Culture Collection, and the
ORF was amplified by PCR. The sequences of the sense and antisense
primers were
5'-GCACCCCATGGTAGGGGGTGGAACGGTAAA-3' and
5'-TACGCTCCCGGGTTAGTGGTGGTGGTGGTGGTGGTAGTTGTTTAAAATACCACATGC-3', respectively. The PCR reaction amplified the entire HP0336 gene sequence and included additional NcoI and XmaI
restriction sites (underlined) at the 5'- and 3'-ends, respectively. In
addition, the PCR reaction introduced a stop codon and six codons for
histidine residues (bold characters) at the 3'-end of the HP0336 gene.
The PCR products were inserted into pTFT74 expression vectors using the
NcoI and XmaI restriction sites. After sequencing the inserted ORF, the pTFT74/HP0336 plasmid was used to transform competent Escherichia coli BL21(DE3) cells. For the
expression of native HcpB, protein cells were grown in LB medium at
37 °C with constant agitation (280 rpm). When an
OD600 of 0.6 was reached, the expression was induced with 1 mM isopropyl- -D-thiogalactopyranoside, and
the culture was grown for an additional 3 h.
Selenomethionine-labeled HcpB was overexpressed in the same strain
using M9 salt medium containing 1 mg/liter biotin and 1 mg/liter
thiamin. 20 min before induction, additional
L-selenomethionine (Sigma, 50 mg/liter), lysine
hydrochloride (100 mg/liter), threonine (100 mg/liter), phenylalanine
(100 mg/liter), leucine (50 mg/liter), isoleucine (50 mg/liter), and
valine (50 mg/liter) were added as solid salts, and the culture was
grown for an additional 13 h after induction.
Isolation of Inclusion Bodies--
HcpB protein was refolded in
a similar way to HcpA (10). Cells were harvested by centrifugation (30 min, 2000 × g, 4 °C), and the pellet was suspended
in 10-20 ml of ice-cold lysis buffer (10 mM Tris/HCl, 2 mM magnesium chloride, pH 6.8). After passing the
suspension two times through a French pressure cell, 50 µg/ml DNase
and 65 µg/ml RNase were added, and the solution was incubated at
37 °C for 30 min. After adding EDTA and CHAPS to final
concentrations of 25 mM and 0.25%, the solution was kept
on ice for an additional 30 min. Inclusion bodies were collected by
centrifugation (15 min, 20,000 × g, 4 °C), and the
soluble fraction was discarded. The pellet was washed two times with
buffer A (0.1 M Tris/HCl, 20 mM EDTA, pH 6.8)
and subsequently buffer B (0.5 M GdmHCl in buffer A).
Inclusion bodies were solubilized in buffer C (5 M GdmHCl, 0.2 M Tris/HCl, 0.1 M
dithiothreitol, 10 mM EDTA, pH 8.0), and insoluble material
was removed by centrifugation. Solubilized inclusion bodies were
dialyzed overnight against buffer D (5 M GdmHCl, 0.1 M acetic acid). Protein concentration was determined by
measuring the absorption at = 280 nm ( 280 = 14,800 M 1 cm 1).
Refolding and Purification--
HcpB was refolded by
immobilizing the solubilized inclusion bodies on a nickel
nitrilotriacetic acid-agarose (Qiagen) and removing the guanidinium
hydrochloride from the buffer. To bind the unfolded inclusion bodies to
the resin, 20 mg of unfolded HcpB was added to 5-10 ml of nickel
nitrilotriacetic acid-agarose in buffer D. After adjusting the pH to
8.0, the slurry was filled into a column. The column was washed with 50 ml of buffer E (5 M GdmHCl, 0.1 M Tris, pH
8.0). HcpB was refolded by replacing buffer E immediately with buffer F
(50 mM Tris/HCl, 150 mM sodium chloride, 5 mM glutathione, pH 8.0) and washing the column with 50 ml
of buffer F at a flow rate of 1 ml/min. The protein was eluted with
buffer G (250 mM imidazole, 50 mM Tris/HCl, 150 mM sodium chloride, 5 mM glutathione, pH 7.0).
Protein containing fractions were pooled and dialyzed against 1000 ml
of buffer H (40 mM sodium acetate, 1 mM EDTA,
pH 5.5). Buffer H was also used for gel-permeation chromatography.
After concentrating the protein in a Centriprep (Millipore), 0.4 ml of
refolded HcpB (1 mg) was loaded onto a Superdex 75 HR 10/30
column (Amersham Biosciences, Inc.) at a flow rate of 0.5 ml/min.
Purified HcpB eluted as a single peak at a volume of 13.47 ml. The
comparison with the calibration profile (blue dextran (2 MDa), 8.63 ml;
bovine serum albumin (67 kDa), 9.97 ml; ovalbumin (43 kDa), 10.90 ml;
chymotrypsinogen A (25 kDa), 13.17 ml; ribonuclease A (13.7 kDa), 14.17 ml) revealed that HcpB eluted as a monomer.
Folding Characterization--
The folding/unfolding behavior of
HcpB was investigated by CD spectroscopy. Spectra were recorded at a
protein concentration of 10 µM in 0-4 M
GdmHCl, 5 mM sodium phosphate, pH 6.9 on a Jasco J-751 CD
spectrometer. The temperature was maintained at 22 °C, and the
data were fitted against Eq. 1 (11). Yobs is
the observed CD signal; a and b and
c and d are the intercepts and the slopes at low
and high GdmHCl concentrations, respectively.
[GdmHCl]1/2 is the GdmHCl
concentration where half of the protein is unfolded, and m
is the cooperativity of the unfolding reaction. R is the ideal gas constant, and T is the absolute
temperature. The theoretical value for the cooperativity of the
unfolding reaction was calculated according to the literature (12).
|
(Eq. 1)
|
|
(Eq. 2)
|
Kinetic Parameters--
The hydrolysis of antibiotics by HcpB
was monitored by following the absorption variation resulting from the
opening of the -lactam ring. Absorption maxima and molar
absorption coefficients are given in Table
I. Ampicillin, amoxicillin, cefotaxim,
cloxacillin, and benzylpenicillin were from Fluka; carbenicillin,
cefalotin, cefoxitin, cephaloridin, and oxacillin were from Sigma; and
nitrocefin was from Becton Dickinson (Franklin Lakes, New York).
All reactions were performed in 20 mM sodium acetate, 150 mM sodium chloride, pH 6.0, at 25 °C on a Cary 300 UV-spectrophotometer. The steady-state rate constants
(Km and kcat) were determined
by fitting all data to the Michaelis-Menten equation using the
KALEIDOGRAPH software. IC50 values were determined by
inhibiting nitocefin hydrolysis at substrate and protein concentrations
of 200 and 2 µM, respectively. Protein concentration was
determined by amino acid analysis.
Crystallization and Data Collection--
Crystallization trials
using the sitting drop vapor diffusion method of native and
selenomethionine-labeled HcpB were set up exactly the same way.
Droplets consisted of 2 µl of reservoir buffer and 2 µl of refolded
HcpB (4.4 mg/ml protein in 40 mM sodium acetate, 1 mM EDTA, pH 5.5). The droplets were equilibrated against 500 µl of reservoir solution (25% polyethylene glycol 8000, 0.1 M sodium citrate, pH 3.0). Pencil-shaped crystals were
obtained within 14 days at 20 °C. They belonged to space group
P6522 with unit cell dimensions a = b = 51.07 Å, c = 206.39 Å, and a
Matthew's parameter of 2.40 Å3/Da with one molecule per
asymmetric unit.
Single crystals were transferred into a cryo-buffer (25% polyethylene
glycol 8000, 0.1 M citrate, 20% ethylene glycol, pH 3.0)
and flash-frozen in a stream of liquid nitrogen at a temperature of 110 K. For phasing by multiple wavelength anomalous dispersion, three data sets were collected up to a 2.5-Å resolution from a single crystal at the BM14 beamline (European Synchrotron Radiation Facility, Grenoble). Later, a further high resolution native
data set was collected at a 1.95-Å resolution on station ID14-3. Data were scaled and integrated using the DENZO/SCALEPACK package (13). Statistics on data collection and refinement are given in Table II.
Structure Solution and Refinement--
The HcpB structure was
solved by multiple wavelength anomalous dispersion phasing using the
selenium absorption edge. Several dispersive and difference Patterson
maps were calculated among the selenomethionine derivative data sets.
To improve the signal to noise ratio, the maps were merged, and the
selenium site was identified by the automated Patterson search method
implemented into the program CNS (14). Heavy atom parameters were
refined using the program SHARP (15). Initial phases were calculated using data between 25- and 3.8-Å resolution. Solvent flattening using
the program SOLOMON (16) revealed an electron density map that was
suitable to build an initial poly-alanine model using the display
software O (17). Subsequently, phases were calculated to a 2.5-Å
resolution, and side chains became visible, allowing the sequence to be
fitted into the electron density. The refinement was performed using
the programs CNS and REFMAC (18). The free R-factor was
calculated with a test set containing 10% of the data. When the
1.95-Å data set became available, refinement was finalized using the
program ArpWarp (19). Amino acids Met-1, Val-2, Asn-136, Asn-137, and
Tyr-138 as well as the six C-terminal histidine residues were not
modeled due to the lack of interpretable electron density. Fold
analysis was performed using the Dali internet service (20).
Figures within this publication were prepared using the programs
MOLSCRIPT (21) and BOBSCRIPT (22). Helix packing angles were calculated
using the program INTERHELIX.
 |
RESULTS |
The HcpB Structure--
The crystal structure analysis of HcpB
revealed, in contrast to the sequence-based secondary structure
prediction, an essentially -helical fold. The 133 residues of HcpB
fold into eight -helices that pack into a right-handed superhelix
with overall dimensions of 63 × 35 × 25 Å (Fig.
2a). Four disulfide bridges
are observed between cysteine pairs Cys-22/Cys-30, Cys-52/Cys-60,
Cys-88/Cys-96, and Cys-124/Cys-132. The disulfide bridges subdivide the
structure into four (1, 2, 3,
4) pairs (A, B) of -helices
confirming the proposed modular architecture. Helices A and B are 14 and 10 residues long, respectively. The two cysteine residues forming a
disulfide bridge are located at the C terminus of helix A and
four residues behind the N terminus of helix B. However, there are
three exceptions. Helix 1A has a three-residue-long -helical
extension at the N terminus, and helix 4B is two residues shorter. In
addition, two residues at the N terminus of helix 1B are not in an
-helical conformation. The packing angle of helices A and B
belonging to the same / -motif (e.g. 1A/1B) is 42°,
whereas the angle between helices B and A of adjacent motifs
(e.g. 1B/2A) is 14°. The helix packing creates a fan-like
structure with an angle between the first and the last -helix of
130° (Fig. 2a). The convex surface of the molecule is
formed by helices 1A, 2A, 3A, and 4A. This surface area is
predominately positively charged. On the opposite side of the molecule,
helices 1B, 2B, 3B, and 4B create an amphipathic groove. Polar side
chains of helix 2B form the bottom of the grove that is flanked on both
sides by hydrophobic side chains coming from helices 1B, 3B, and
4B.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
a, ribbon diagram showing also the
disulfide bridges in HcpB. The four / -motifs are
shaded and labeled. b, stereo view of
the superposition of four HcpB / -motifs. Motifs are
shaded as in panel a. The superposition was
calculated based on the residue selection given in Table III. The side
chains of amino acids that are conserved in all four motifs are
depicted. Numbering refers to the position in the motif as
indicated in panel c. c, structure-based sequence
alignment of HcpB motifs 1-4 and PP5 TPR repeats 1-3. Residues
that are conserved are highlighted: surface residues (blue),
cysteine residues (green), residues with small side chains (yellow), and hydrophobic side
chains (red). Helices and numbering on the
top refer to the HcpB motif. The TPR numbering
and helix assignment is given at the bottom. Small
hydrophobic residues that are conserved in TPRs are boxed.
d, stereo view of the C traces of TPR repeats 1 (blue), 2 (red), and 3 (green)
superimposed individually onto HcpB (yellow).
|
|
The four -helix pairs possess very similar conformations
(Fig. 2b). The sequence identity for the pairwise alignments
varies between 33 and 58%, and the root mean square deviation
(r.m.s.d.) varies between 0.33 and 1.35 Å (Table
III). Although the overall sequence
composition of motif 1 is similar to motifs 2-4, the conformation of
motif 1 is different from motifs 2-4. The r.m.s.d. between motif 1 and
motifs 2-4 is well above 1 Å, whereas the r.m.s.d. among motifs 2-4
is much smaller (Table III). The increased r.m.s.d. is due to a
different conformation of the loop that connects helices 1A and 1B. In
loop 1, the amino acid at position 26 is in the left-handed helix
conformation ( / Phe-28 = 70°/3°), whereas the
corresponding residues in loops 2-4 are all in right-handed helix
conformations ( / Asn-58 = 56°/ 40°,
/ Asp-94 = 83°/ 33°, and /
Asp-130 = 54°/ 38°).
The structure-based sequence alignment of the four motifs reveals that
the sequence pattern extends beyond the conserved cysteine pairs (Fig.
2c). The cysteine residues at positions 20 and 28, alanine
at position 19, and glycine at position 27 are conserved for structural
reasons. The disulfide bridge fixes helices A and B in a defined
orientation and restrains the conformation of the loop. The covalent
disulfide bond brings the helices very close together in space.
Therefore the side chains of residues preceding the cysteines
(e.g. alanine at position 19 and glycine at position 27) are
at van der Waals distances. Throughout the whole Hcp family, residues
preceding the cysteines are always glycine, alanine, or serine residues
because these residue types possess sufficiently small side chains.
Residues with larger side chains would prevent helices A and B from
adopting the proper packing angles. Leucine at position 31 is also
conserved because its side chain fits like a knob into a hole on the
surface of the preceding helix A. The leucine at position 31 in motif 1 (Leu-33) is completely buried in the center of a hydrophobic core
formed by helices 1A, 1B, and 2A, whereas leucine residues in motifs
2-4 (Leu-63, Leu-99, and Leu-135) are solvent accessible. In addition,
lysine residues at positions 11 and 18, leucine residues at position
22, and asparagine residues at position 14 are also conserved (Fig. 2,
b and c). Since these amino acids occur in
subsequent turns on the solvent-exposed side of helix A, they form rims
of identical residues on the convex side of the molecule.
Data base searches revealed that the structure of HcpB is most similar
to the tetratricopeptide repeat (TPR) domain of the human protein
phosphatase 5 (PP5, Protein Data Bank accession number 1a17) (23). The
isolated PP5 TPR repeats superimpose well onto the HcpB structure (Fig.
2d). However, the relative orientation of repeats in HcpB
and PP5 are different.
Characterization of Folding--
Since HcpB was refolded from
inclusion bodies, proper refolding was verified by CD spectroscopy. The
CD spectrum shown in Fig. 3a
reveals a pronounced minimum at 222 nm. Based on the CD spectrum, the
-helix content was predicted to be 73%, which is in perfect
agreement with the crystal structure. Upon the addition of GdmHCl, the
minimum at 222 nm vanishes from the spectrum. By plotting the CD signal
at 222 nm over the GdmHCl concentration, the free energy of unfolding
and the cooperativity parameter (m) were determined from the
intercepts and the slopes of the titration curve at the transition
phase. From the titration curve shown in Fig. 3b, we derived
[GdmHCl]1/2 and m values of
1.93 ± 0.02 M and 11.24 ± 0.99 kJ/(mol·M), respectively, yielding a free energy of
unfolding of 22 kJ/mol. The theoretical cooperativity of unfolding
calculated from the amino acid sequence is 12 kJ/(mol·M).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3.
a, CD spectrum of refolded HcpB.
b, ellipticity at a wavelength of 222 nm as a function of
GdmHCl concentration. mdeg, millidegrees.
|
|
-Lactam Hydrolysis--
It was shown recently that HcpA has
-lactamase and penicillin binding activities (10). Kinetic data
summarized in Table I reveal that HcpB possesses similar activities.
Generally, 6-aminopenicillinic acid compounds are better substrates or
inhibitors than 7-aminocephalosporanic acid derivatives. With the
exception of nitrocefin, 6-aminopenicillinic acid derivatives show
Km and IC50 values in the micromolar range, whereas the kinetic parameters for 7-aminocephalosporanic acid
derivatives are in the millimolar range.
The Binding Site--
Attempts to detect the nitrocefin binding
site in HcpB failed because the crystals disintegrated upon soaking
nitrocefin into the HcpB crystals. However, the crystal color turned
dark red, indicating that the nitrocefin -lactam ring was cleaved by
HcpB. Electron density maps calculated between the refined HcpB
structure and x-ray diffraction data collected on HcpB co-crystallized
with oxacillin (data not shown) revealed significant difference
electron density in the amphipathic grove, but the maps were not
sufficiently clear to fit oxacillin precisely into the HcpB structure.
Upon refinement of the HcpB crystal structure, we observed strong
electron density at the putative penicillin binding site. This density
was refined as a cluster of densely packed water molecules as shown in
Fig. 4a. However, the close
distances of water molecules and the continuous electron density
suggest that this density might represent a copurified ligand rather
than a cluster of isolated water molecules. Mass spectrometric analysis of HcpB revealed two peaks with molecular masses of 16,159.2 and 16,450.8 Da (data not shown). The two peaks account for a mixture of
free HcpB and a complex between HcpB and a compound with a molecular
weight of ~292 Da. N-acetylmuramic acid (NAM) is a
compound that is found in the peptidoglycan of all Gram-negative
bacteria. NAM has the right molecular size (molecular size = 293.3 Da) and fits the observed electron density as indicated in Fig.
4a. The proposed binding site is located in the amphipathic
grove close to the N termini of helices 1B, 2B, and 3B (Fig.
4b). Modeling NAM into the proposed binding site revealed
that NAM would be recognized by a number of hydrogen bonds. Residues
that could interact with the putative ligand are Asn-58, Asp-92,
Asp-94, and Ser-128.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 4.
a, water molecules and 2Fo-Fc
electron density (contour level of 1.3 ) in the putative ligand
binding site. The density is explained by 11 water molecules.
N-acetylmuramic acid was modeled into the electron density
of the water molecule cluster. b, modeled
N-acetylmuramic acid/HcpB complex. The ligand could form
hydrogen bonds with residues in the loops between helices A and B of
motifs 1, 2, and 3.
|
|
 |
DISCUSSION |
The conservation of the sequence pattern among the Hcp family
suggests that all family members are composed of the same
/ -motif. This motif is similar to the TPR repeat, although there
are substantial differences. As the name implies, TPR proteins consist
of repeats of 34 amino acids that fold into two -helices and are
frequently found in multidomain proteins where they serve as
protein/protein interaction modules. The TPR sequences are very
versatile, and there is no position characterized by an invariant
residue. Small hydrophobic residues are observed at positions 8, 20, and 27 of the TPR motif. The sequence alignment deduced from the
superposition of the HcpB motifs onto the three TPRs of PP5 reveals
that this pattern is partially conserved in the HcpB structure (Fig.
2c). The alanine/leucine residues at positions 12 and 19 of
the HcpB motif superimpose onto the alanine/valine residues at
positions 20 and 27 of the TPR. In addition, leucine at position 22 is
also conserved in TPR repeats 1 and 2, whereas the lysine and
asparagine residues at positions 11, 14, and 18 that are located on the
convex surface of HcpB are not. There might be a functional requirement for the conservation of these amino acids, particularly if HcpB interacts with proteins that also show a modular architecture. On the
other hand, the conservation might be a remnant from the duplication of
an ancestral / -motif sequence. Since many residues that
participate in helix packing are not conserved among HcpB motifs, it
seems that there is a selective pressure for the conservation of these
surface residues.
However, the TPR and Hcp repeats consist of 34 and 36 amino acids,
respectively. In HcpB, four amino acids are inserted between helices A
and B of the TPR. The loop between cysteine pairs that is conserved
throughout the Hcp family is two amino acids shorter in TPR proteins
(Fig. 2, c and d). In HcpB, the inter- and
intra-repeat helix packing angles are 42° and 14°, respectively,
whereas in TPR proteins, these angles are always ~24°. Therefore
the Hcp and TPR folds are related because they consist of similar pairs of antiparallel -helices. However, the loops connecting the helices and the helix packing angles are different.
The biological functions of TPR proteins are very diverse. Many TPR
proteins are involved in regulation of the cell cycle, in protein
transport, and in chaperone-assisted protein folding (24), which makes
it impossible to assign a possible biological function to HcpB based on
the overall structural topology alone. Most members of the Hcp family
have only been recognized on the genome level. In vivo
expression was shown for the gene products of HP0211 and HP0160. HP0211
messenger RNA (designated orf2 in the literature (25)) was
detected by slot-blot analysis, and the gene product (HcpA) was
recognized in H. pylori culture broth supernatant, verifying
that this gene was expressed and secreted into the medium (9). In
another study, the HP0160 gene product was identified in H. pylori membrane fractions (26).
It was shown that HcpA had a moderate -lactamase activity (10) and
the HP0160 gene product (PBP4) is capable of binding penicillin
derivatives (26). HcpB possesses a penicillin binding activity like
other Hcp family members. The substrate profile shows that HcpB must be
regarded as a penicillinase because most 7-aminocephalosporanic acid
derivatives are neither good substrates nor tight binding inhibitors.
The substrate profiles of HcpA and -B are similar, but there are also
subtle differences that distinguish these family members. The
Km value for amoxicillin hydrolysis by HcpB is three
times smaller than for HcpA, whereas for benzylpenicillin, this
relationship is inverted. The turnover rates for -lactam hydrolysis
by HcpA and -B are 5 orders of magnitude lower than for typical
-lactamases such as the Bacillus licheniformis
-lactamase, but they are still 4 orders of magnitude higher than for
typical penicillin-binding proteins (PBP) such as the
Streptomyces R61 DD-peptidase (27).
A possible explanation why the turnover rates are much lower than for
known -lactamases might be that the true activities are
substantially higher, but only a small fraction of HcpB refolded into
an active conformation. Although this hypothesis can ultimately be
tested only by the analysis of HcpB that has been isolated from natural
sources, there is little evidence to support this idea. If the measured
-lactamase activities would be exerted by a small fraction of
correctly refolded protein, there should be considerable batch-to-batch
variation, and the kcat values of HcpA and -B
should differ significantly. However, the measured turnover rates for
HcpA and -B are very similar, and the kcat error
is just 0.1 min 1. The fact that two different proteins
that have been refolded under different conditions possess very similar
kcat values makes it unlikely that the natural
activities are substantially higher than the measured activities. On
the other hand, the true activities might just be slightly bigger than
the measured activities, and the protein preparation may consist of
equally sized fractions of active and inactive protein conformations.
In this case, one would expect that the GdmHCl titration curve would
show a multiphase transition, which is not the case. In fact the
measured cooperativity of unfolding agrees very well with the
theoretical value.
The kinetic data given in Table I characterize HcpA and -B as
intermediates between classical PBPs and true -lactamases. Although
-lactamases and PBP have evolved from a common ancestor, which is
indicated by similar active site topologies and three-dimensional folds, their biological functions are different (27). Classical PBPs
are involved in peptidoglycan biosynthesis where they catalyze the
glycan chain elongation and cross-linking. Therefore high molecular
weight PBPs are bifunctional. They contain a
D-Ala-D-Ala-specific transpeptidase activity
that can be inhibited by -lactam antibiotics and a transglycosylase
activity (28). In contrast to PBPs, -lactamases have evolved to
combat treatment with -lactam antibiotics. -lactamases are very
potent enzymes that rapidly hydrolyze -lactam antibiotics to prevent
inhibition of PBPs. None of the members of the Hcp family possess
significant sequence or structural similarity with the currently known
-lactamases or PBPs, and the well known sequence motif that is
ubiquitously found in active site serine PBPs (28) is also absent
throughout the Hcp family. Therefore the in vivo functions
of HcpA and -B still remain unclear. Due to their moderate turnover
rates, it is unlikely that these enzymes confer significant resistance
against antibiotics by -lactam hydrolysis, which is also supported
by the observation that the H. pylori strain 26695 is still
sensitive to amoxicillin (29).
HcpA and -B could also be involved in the biosynthesis of
peptidoglycan, which is supported by the chemical similarity between penicillins and the D-Ala-D-Ala dipeptide that
is cleaved upon cross-linking of adjacent glycan strains. PBPs that
catalyze this reaction play a crucial role in maintaining the cellular
morphology (30). H. pylori possesses a characteristic
spiral-shaped morphology, suggesting that the biosynthesis of the
H. pylori peptidoglycan has some unique features (31).
Genome analysis revealed that there are three PBP homologues but only
one of them has a proposed transglycosylation activity (32). Since no
additional monofunctional transglycosylases were found by sequence
comparison methods, there is just one enzyme that can catalyze the
glycan chain elongation and recycling of proteoglycan fragments.
The spirulate morphology of H. pylori might either be
attributed to the lack of transglycosylases or to alternative enzymes
that participate in proteoglycan metabolism. Perhaps proteins from the
Hcp family are responsible for the spiral-shaped morphology of H. pylori.
The HcpB crystal structure is the prototype structure for a protein
family that is restricted to the Helicobacter and
Campylobacter genera. So far, all investigated proteins from
this family possess penicillin binding activities. However, the
biological functions are still unclear. Therefore further in
vivo experiments to elucidate the biological functions of these
proteins in more detail are needed.
 |
ACKNOWLEDGEMENTS |
We thank Ragna Sack and Drs. Peter
Gehrig and Peter Hunziker for mass spectrometric analysis. The support
of data collection of Drs. Germaine Sainz and Gordon Leonard on station
BM14 and Drs. Julien Lescar and Ed Mitchel on station ID14-3 (European Synchrotron Radiation Facility, Grenoble) is also gratefully acknowledged.
 |
FOOTNOTES |
*
This work was supported by the Hartmann-Müller
Foundation (Zürich/CH), the Baugarten Stiftung (Zürich/CH),
and Grant 3100-063794.001 from the Swiss National Science Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1KLX) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
To whom correspondence should be addressed. Tel.: 41-1-635-6559;
Fax: 41-1-635-6834; E-mail: mittl@bioc.unizh.ch.
Published, JBC Papers in Press, January 2, 2002, DOI 10.1074/jbc.M108993200
 |
ABBREVIATIONS |
The abbreviations used are:
ORF, open
reading frame;
GdmHCl, guanidinium hydrochloride;
Hcp, Helicobacter cysteine-rich protein;
NAM, N-acetylmuramic acid;
PP5, human protein phosphatase 5;
TPR
tetratricopeptide repeat, PBP, penicillin-binding proteins;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.
 |
REFERENCES |
| 1.
|
Warren, J. R.,
and Marshal, B.
(1983)
Lancet
1,
1273-1275[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Blaser, M. J.,
Perez-Perez, G. I.,
Kleanthous, H.,
Cover, T. L.,
Peek, R. M.,
Chyou, P. H.,
Stemmermann, G. N.,
and Nomura, A.
(1995)
Cancer Res.
55,
2111-2115[Abstract/Free Full Text]
|
| 3.
|
Graham, D. Y.,
and Yamaoka, Y.
(1998)
Helicobacter
3,
145-151[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
McGee, D. J.,
and Mobley, H. L.
(1999)
Curr. Top. Microbiol. Immunol.
241,
155-180[Medline]
[Order article via Infotrieve]
|
| 5.
|
Covacci, A.,
Telford, J. L.,
Del Giudice, G.,
Parsonnet, J.,
and Rappuoli, R.
(1999)
Science
284,
1328-1333[Abstract/Free Full Text]
|
| 6.
|
Powell, J.,
and McConkey, C. C.
(1992)
Eur. J. of Cancer Prev.
1,
265-269
|
| 7.
|
Tomb, J. F.,
White, O.,
Kerlavage, A. R.,
Clayton, R. A.,
Sutton, G. G.,
Fleischmann, R. D.,
Ketchum, K. A.,
Klenk, H. P.,
Gill, S.,
Dougherty, B. A.,
Nelson, K.,
Quackenbush, J.,
Zhou, L.,
Kirkness, E. F.,
Peterson, S.,
Loftus, B.,
Richardson, D.,
Dodson, R.,
Khalak, H. G.,
Glodek, A.,
McKenney, K.,
Fitzegerald, L. M.,
Lee, N.,
Adams, M. D.,
and Venter, J. C.
(1997)
Nature
388,
539-547[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Alm, R. A.,
Ling, L. S.,
Moir, D. T.,
King, B. L.,
Brown, E. D.,
Doig, P. C.,
Smith, D. R.,
Noonan, B.,
Guild, B. C.,
deJonge, B. L.,
Carmel, G.,
Tummino, P. J.,
Caruso, A.,
Uria-Nickelsen, M.,
Mills, D. M.,
Ives, C.,
Gibson, R.,
Merberg, D.,
Mills, S. D.,
Jiang, Q.,
Taylor, D. E.,
Vovis, G. F.,
and Trust, T. J.
(1999)
Nature
397,
176-180[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Cao, P.,
McClain, M. S.,
Forsyth, M. H.,
and Cover, T. L.
(1998)
Infect. Immun.
66,
2984-2986[Abstract/Free Full Text]
|
| 10.
|
Mittl, P. R. E.,
Lüthy, L.,
Hunziker, P.,
and Grütter, M. G.
(2000)
J. Biol. Chem.
275,
17693-17699[Abstract/Free Full Text]
|
| 11.
|
Santoro, M. M.,
and Bolen, D. W.
(1988)
Biochemistry
27,
8063-8068[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Myers, J. K.,
Pace, C. N.,
and Scholtz, J. M.
(1995)
Protein Sci.
4,
2138-2148[Medline]
[Order article via Infotrieve]
|
| 13.
|
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276,
307-326[CrossRef]
|
| 14.
|
Brunger, A. T.,
Adams, P. D.,
Clore, G. M.,
DeLano, W. L.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J. S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
D905-D921[CrossRef]
|
| 15.
|
Brodersen, D. E.,
de La Fortelle, E.,
Vonrhein, C.,
Bricogne, G.,
Nyborg, J.,
and Kjeldgaard, M.
(2000)
Acta Crystallogr. Sect. D Biol. Crystallogr.
56,
D431-D441[CrossRef]
|
| 16.
|
Abrahams, J. P.,
and Leslie, A. G. W.
(1996)
Acta Crystallogr. Sect. D Biol. Crystallogr.
52,
D40-D42
|
| 17.
|
Jones, T. A.,
Zou, J. Y.,
Cowan, S. W.,
and Kjeldgaard.
(1991)
Acta Crystallogr. Sect. A
47,
A110-A119[CrossRef]
|
| 18.
|
Murshudov, G. N.,
Vagin, A. A.,
Lebedev, A.,
Wilson, K. S.,
and Dodson, E. J.
(1999)
Acta Crystallogr. Sect. D Biol. Crystallogr.
55,
D247-D255[CrossRef]
|
| 19.
|
Perrakis, A.,
Morris, R.,
and Lamzin, V. S.
(1999)
Nat. Struct. Biol.
6,
458-463[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Holm, L.,
and Sander, C.
(1993)
J. Mol. Biol.
233,
123-138[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
|
| 22.
|
Esnouf, R. M.
(1997)
J. Mol. Graph. Model
15,
132-134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Das, A. K.,
Cohen, P. W.,
and Barford, D.
(1998)
EMBO J.
17,
1192-1199[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Blatch, G. L.,
and Lassle, M.
(1999)
Bioessays
21,
932-939[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Karita, M.,
Etterbeek, M. L.,
Forsyth, M. H.,
Tummuru, M. K.,
and Blaser, M. J.
(1997)
Infect Immun.
65,
4158-4164[Abstract]
|
| 26.
|
Krishnamurthy, P.,
Parlow, M. H.,
Schneider, J.,
Burroughs, S.,
Wickland, C.,
Vakil, N. B.,
Dunn, B. E.,
and Phadnis, S. H.
(1999)
J. Bacteriol.
181,
5107-5110[Abstract/Free Full Text]
|
| 27.
|
Kelly, J. A.,
Dideberg, O.,
Charlier, P.,
Wery, J. P.,
Libert, M.,
Moews, P. C.,
Knox, J. R.,
Duez, C.,
Fraipont, C.,
and Joris, B.
(1986)
Science
231,
1429-1431[Abstract/Free Full Text]
|
| 28.
|
Massova, I.,
and Mobashery, S.
(1998)
Antimicrob. Agents Chemother.
42,
1-17[Free Full Text]
|
| 29.
|
Simala-Grant, J. L.,
Zopf, D.,
and Taylor, D. E.
(2001)
J. Antimicrob. Chemother.
47,
555-563[Abstract/Free Full Text]
|
| 30.
|
Nelson, D. E.,
and Young, K. D.
(2001)
J. Bacteriol.
183,
3055-3064[Abstract/Free Full Text]
|
| 31.
|
Costa, K.,
Bacher, G.,
Allmaier, G.,
Dominguez-Bello, M. G.,
Engstrand, L.,
Falk, P.,
de Pedro, M. A.,
and Garcia-del Portillo, F.
(1999)
J. Bacteriol.
181,
3710-3715[Abstract/Free Full Text]
|
| 32.
|
Doig, P.,
de Jonge, B. L.,
Alm, R. A.,
Brown, E. D.,
Uria-Nickelsen, M.,
Noonan, B.,
Mills, S. D.,
Tummino, P.,
Carmel, G.,
Guild, B. C.,
Moir, D. T.,
Vovis, G. F.,
and Trust, T. J.
(1999)
Microbiol. Mol. Biol. Rev.
63,
675-707[Abstract/Free Full Text]
|
| 33.
|
Thompson, J. D.,
Gibson, T. J.,
Plewniak, F.,
Jeanmougin, F.,
and Higgins, D. G.
(1997)
Nucleic Acids Res.
25,
4876-4882[Abstract/Free Full Text]
|
| 34.
|
Nielsen, H.,
Engelbrecht, J.,
Brunak, S.,
and von Heijne, G.
(1997)
Int. J. Neural Syst.
8,
581-599[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Parkhill, J.,
Wren, B. W.,
Mungall, K.,
Ketley, J. M.,
Churcher, C.,
Basham, D.,
Chillingworth, T.,
Davies, R. M.,
Feltwell, T.,
Holroyd, S.,
Jagels, K.,
Karlyshev, A. V.,
Moule, S.,
Pallen, M. J.,
Penn, C. W.,
Quail, M. A.,
Rajandream, M. A.,
Rutherford, K. M.,
van Vliet, A. H.,
Whitehead, S.,
and Barrell, B. G.
(2000)
Nature
403,
665-668[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Deml, M. Aigner, J. Decker, A. Eckhardt, C. Schutz, P. R. E. Mittl, S. Barabas, S. Denk, G. Knoll, N. Lehn, et al.
Characterization of the Helicobacter pylori Cysteine-Rich Protein A as a T-Helper Cell Type 1 Polarizing Agent
Infect. Immun.,
August 1, 2005;
73(8):
4732 - 4742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Suzuki, A. Neutzner, N. Tjandra, and R. J. Youle
Novel Structure of the N Terminus in Yeast Fis1 Correlates with a Specialized Function in Mitochondrial Fission
J. Biol. Chem.,
June 3, 2005;
280(22):
21444 - 21452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. E. Mittl, L. Luthy, C. Reinhardt, and H. Joller
Detection of High Titers of Antibody against Helicobacter Cysteine-Rich Proteins A, B, C, and E in Helicobacter pylori-Infected Individuals
Clin. Vaccine Immunol.,
July 1, 2003;
10(4):
542 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Deka, M. Machius, M. V. Norgard, and D. R. Tomchick
Crystal Structure of the 47-kDa Lipoprotein of Treponema pallidum Reveals a Novel Penicillin-binding Protein
J. Biol. Chem.,
October 25, 2002;
277(44):
41857 - 41864.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|